Wellbeing Digital Sciences Inc.

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, EXE.TO has a market cap of 2.6B. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while EXE.TO trades at CA$27.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas EXE.TO's P/E ratio is 25.01. In terms of profitability, MEDI.NE's ROE is N/A, compared to EXE.TO's ROE of +0.48%. Regarding short-term risk, MEDI.NE is more volatile compared to EXE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check EXE.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, SIA.TO has a market cap of 2.2B. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while SIA.TO trades at CA$22.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas SIA.TO's P/E ratio is 45.73. In terms of profitability, MEDI.NE's ROE is N/A, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, MEDI.NE is more volatile compared to SIA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check SIA.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, DNTL.TO has a market cap of 2.1B. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while DNTL.TO trades at CA$11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas DNTL.TO's P/E ratio is -78.57. In terms of profitability, MEDI.NE's ROE is N/A, compared to DNTL.TO's ROE of -0.02%. Regarding short-term risk, MEDI.NE is more volatile compared to DNTL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check DNTL.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, WELL.TO has a market cap of 996.3M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while WELL.TO trades at CA$3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas WELL.TO's P/E ratio is -130.00. In terms of profitability, MEDI.NE's ROE is N/A, compared to WELL.TO's ROE of -0.01%. Regarding short-term risk, MEDI.NE is more volatile compared to WELL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check WELL.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, DR.TO has a market cap of 298.2M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while DR.TO trades at CA$16.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas DR.TO's P/E ratio is 15.02. In terms of profitability, MEDI.NE's ROE is N/A, compared to DR.TO's ROE of +0.28%. Regarding short-term risk, MEDI.NE is more volatile compared to DR.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check DR.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, AIDX.TO has a market cap of 237.6M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while AIDX.TO trades at CA$0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas AIDX.TO's P/E ratio is -5.40. In terms of profitability, MEDI.NE's ROE is N/A, compared to AIDX.TO's ROE of -0.39%. Regarding short-term risk, MEDI.NE is more volatile compared to AIDX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check AIDX.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, CRRX.TO has a market cap of 221.4M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while CRRX.TO trades at CA$3.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas CRRX.TO's P/E ratio is 8.61. In terms of profitability, MEDI.NE's ROE is N/A, compared to CRRX.TO's ROE of +0.28%. Regarding short-term risk, MEDI.NE is more volatile compared to CRRX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check CRRX.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, DRDR.TO has a market cap of 49.4M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while DRDR.TO trades at CA$0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas DRDR.TO's P/E ratio is -0.83. In terms of profitability, MEDI.NE's ROE is N/A, compared to DRDR.TO's ROE of -1.02%. Regarding short-term risk, MEDI.NE is more volatile compared to DRDR.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check DRDR.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while GTMS.TO trades at CA$0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, MEDI.NE's ROE is N/A, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, MEDI.NE is more volatile compared to GTMS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check GTMS.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, NUMI.TO has a market cap of 16M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while NUMI.TO trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas NUMI.TO's P/E ratio is -0.63. In terms of profitability, MEDI.NE's ROE is N/A, compared to NUMI.TO's ROE of +11.51%. Regarding short-term risk, MEDI.NE is more volatile compared to NUMI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check NUMI.TO's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, EPW.CN has a market cap of 4.1M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while EPW.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas EPW.CN's P/E ratio is -0.27. In terms of profitability, MEDI.NE's ROE is N/A, compared to EPW.CN's ROE of +0.47%. Regarding short-term risk, MEDI.NE is more volatile compared to EPW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check EPW.CN's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, CALM.CN has a market cap of 2.8M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while CALM.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas CALM.CN's P/E ratio is -0.11. In terms of profitability, MEDI.NE's ROE is N/A, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, MEDI.NE is more volatile compared to CALM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check CALM.CN's competition here

MEDI.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDI.NE stands at 17.8K. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, MEDI.NE is priced at CA$0.01, while OMIC.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDI.NE currently has a P/E ratio of -0.02, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, MEDI.NE's ROE is N/A, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, MEDI.NE is more volatile compared to OMIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for MEDI.NE.Check OMIC.CN's competition here